MPLT vs SLB · $1.24B cap vs P/E 12, rev $8.97B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
MPLT does not have a complete income-statement cache yet.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
MPLT currently screens at market cap $1.24B. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the MPLT and SLB stock pages for the full models.
Not investment advice.